Xioasha Zhang

PULSAR: A phase 2, randomized, double-blind, placebo-controlled study to assess the efficacy and safety of sotatercept (ACE-011) when added to standard of care (SOC) for treatment of pulmonary arterial hypertension (PAH)

M. Humbert, R. Zeldin, D. Badesch, 2019, Pulmonary hypertension.